Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Dyslipidemia

  Free Subscription


22.06.2020

2 Circulation
2 Lancet Public Health
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Circulation

  1. ARNETT DK, Blumenthal RS, Albert MA, Buroker AB, et al
    2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.
    Circulation. 2019 Mar 17:CIR0000000000000678. doi: 10.1161/CIR.0000000000000678.
    PubMed        

  2. ARNETT DK, Blumenthal RS, Albert MA, Buroker AB, et al
    2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary.
    Circulation. 2019 Mar 17:CIR0000000000000677. doi: 10.1161/CIR.0000000000000677.
    PubMed        


    Lancet Public Health

  3. WENG S, Kai J, Akyea R, Qureshi N, et al
    Detection of familial hypercholesterolaemia: external validation of the FAMCAT clinical case-finding algorithm to identify patients in primary care.
    Lancet Public Health. 2019;4:e256-e264.
    PubMed         Abstract available

  4. WATTS GF, Pang J
    A window into the heart of familial hypercholesterolaemia in the community.
    Lancet Public Health. 2019;4:e216-e217.
    PubMed        


    PLoS One

  5. SAGAR D, Gaddipati R, Ongstad EL, Bhagroo N, et al
    LOX-1: A potential driver of cardiovascular risk in SLE patients.
    PLoS One. 2020;15:e0229184.
    PubMed         Abstract available

  6. BARTHOLD D, Joyce G, Diaz Brinton R, Wharton W, et al
    Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk.
    PLoS One. 2020;15:e0229541.
    PubMed         Abstract available

  7. LI C, Ma R, Zhang X, Ma J, et al
    Risk of coronary heart disease in the rural population in Xinjiang: A nested case-control study in China.
    PLoS One. 2020;15:e0229598.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: